Modulation of Circulating Levels of the Ketone Body 3-hydroxybutyrate in Patients With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction: Metabolic Effects. (KETO-HFpEF-Metabolic)

NCT05159570 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction
Diabetes Mellitus, Type 2
Ketonemia

Interventions

DIETARY_SUPPLEMENT: Ketone ester
DIETARY_SUPPLEMENT: Placebo drink

Sponsor

University of Aarhus